These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 24595566

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study.
    Daudén E, Pujol RM, Sánchez-Carazo JL, Toribio J, Vanaclocha F, Puig L, Yébenes M, Sabater E, Casado MA, Caloto MT, Aragón B, VACAP Study Investigators.
    Actas Dermosifiliogr; 2013 Nov; 104(9):807-14. PubMed ID: 23827342
    [Abstract] [Full Text] [Related]

  • 3. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
    Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD.
    Rheumatology (Oxford); 2012 Mar; 51(3):571-6. PubMed ID: 22157469
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.
    Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, Horváth G, Koó E, Polgár A, Seszták M, Szántó S, Ujfalussy I, Gulácsi L.
    Scand J Rheumatol; 2010 Aug; 39(4):303-9. PubMed ID: 20166848
    [Abstract] [Full Text] [Related]

  • 5. Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
    Feldman SR, Gottlieb AB, Bala M, Wu Y, Eisenberg D, Guzzo C, Li S, Dooley LT, Menter A.
    Br J Dermatol; 2008 Sep; 159(3):704-10. PubMed ID: 18627375
    [Abstract] [Full Text] [Related]

  • 6. Health-related quality of life in psoriatic arthritis patients in Spain.
    Gratacós J, Daudén E, Gómez-Reino J, Moreno JC, Casado MÁ, Rodríguez-Valverde V.
    Reumatol Clin; 2014 Sep; 10(1):25-31. PubMed ID: 24099960
    [Abstract] [Full Text] [Related]

  • 7. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
    Youn SW, Lee JH, Yu DY, Kim Y, Kim BS, Seo SJ, Choe YB, Yun SK, Park J, Kim NI, Choi CW, Youn JI, Lee SJ, Lee MG, Kim KJ, Park CJ, Ro YS, Song HJ, Shin BS, Ahn SK, Lee JY, Won YH, Jang MS, Kim KH, Kim MH, Kim TY, Choi JH.
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.
    Reich K, Krüger K, Mössner R, Augustin M.
    Br J Dermatol; 2009 May; 160(5):1040-7. PubMed ID: 19210498
    [Abstract] [Full Text] [Related]

  • 9. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
    Revicki DA, Willian MK, Menter A, Saurat JH, Harnam N, Kaul M.
    Dermatology; 2008 May; 216(3):260-70. PubMed ID: 18187944
    [Abstract] [Full Text] [Related]

  • 10. Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial.
    Kavanaugh A, Menter A, Mendelsohn A, Shen YK, Lee S, Gottlieb AB.
    Curr Med Res Opin; 2010 Oct; 26(10):2385-92. PubMed ID: 20831455
    [Abstract] [Full Text] [Related]

  • 11. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
    Haugeberg G, Michelsen B, Kavanaugh A.
    RMD Open; 2020 May; 6(1):. PubMed ID: 32409518
    [Abstract] [Full Text] [Related]

  • 12. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
    Kalb RE, Blauvelt A, Sofen HL, Chevrier M, Amato D, Calabro S, Wang J, Schenkel B, Gottlieb AB.
    J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
    [Abstract] [Full Text] [Related]

  • 13. Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey.
    Moradi M, Rencz F, Brodszky V, Moradi A, Balogh O, Gulácsi L.
    Arch Iran Med; 2015 Mar; 18(3):153-9. PubMed ID: 25773688
    [Abstract] [Full Text] [Related]

  • 14. Disease characteristics in patients with and without psoriatic arthritis treated with etanercept.
    Papp K, Poulin Y, Vieira A, Shelton J, Poulin-Costello M.
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):581-9. PubMed ID: 23465037
    [Abstract] [Full Text] [Related]

  • 15. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
    Blackmore MG, Gladman DD, Husted J, Long JA, Farewell VT.
    J Rheumatol; 1995 May; 22(5):886-93. PubMed ID: 8587077
    [Abstract] [Full Text] [Related]

  • 16. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?
    Tezel N, Yilmaz Tasdelen O, Bodur H, Gul U, Kulcu Cakmak S, Oguz ID, Karabulut E.
    Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852
    [Abstract] [Full Text] [Related]

  • 17. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R, Willian MK, Okun MM, Thompson CS, Revicki DA.
    Health Qual Life Outcomes; 2006 Sep 27; 4():71. PubMed ID: 17005043
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies.
    Kavanaugh A, Gottlieb A, Morita A, Merola JF, Lin CY, Birt J, Shuler CL, Hufford MM, Thaçi D.
    Ann Rheum Dis; 2019 Sep 27; 78(9):1215-1219. PubMed ID: 31113794
    [Abstract] [Full Text] [Related]

  • 20. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
    Norlin JM, Steen Carlsson K, Persson U, Schmitt-Egenolf M.
    Br J Dermatol; 2012 Apr 27; 166(4):797-802. PubMed ID: 22182212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.